The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif

Molecular Cell

Volumn 7, Issue 2, 2001, Pages 377-385

  Constantinescu, Stefan N ^a   Huang, Lily Jun shen ^a   Nam, Hyung song ^a   Lodish, Harvey F ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYTOKINE RECEPTOR; ERYTHROPOIETIN RECEPTOR; JANUS KINASE;

ALPHA HELIX; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; ENZYME ACTIVATION; HYDROPHOBICITY; MOUSE; MUTAGENESIS; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALIA; JANUS;

EID: 0035102191     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00185-X     Document Type: Article

References (31)

1. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: Mapping of the Jak3-receptor interaction domain
2. The FERM domain: A unique module involved in the linkage of cytoplasmic proteins to membrane
3. Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain
4. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation
5. Jak-STAT Pathways and transcriptional activation in response to IFN's and other extracellular signaling proteins
6. Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies
7. The N-termini of FAK and JAKs contain divergent band 4.1 domains
8. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation
9. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6
10. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor
11. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5
12. Generation of mammalian cells stably expressing multiple genes at predetermined levels
13. Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 A
14. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation
15. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
16. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family
17. Chimeric erythropoietin-interferon gamma receptors reveal differences in functional architecture of intracellular domains for signal transduction
18. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
19. II-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo
20. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain
21. Erythropoietin receptor activation by a ligand-induced conformation change
22. Prediction of protein secondary structure at better than 70% accuracy
23. PHD: An automatic mail server for protein secondary structure prediction
24. Erythroleukaemia induction by the Friend spleen focus-forming virus
25. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-X(L) induction
26. Efficiency of signalling through cytokine receptors depends critically on receptor orientation
27. Homodimerization and constitutive activation of the erythropoietin receptor
28. Cytokine receptor signal transduction and the control of hematopoietic cell development
29. Small peptides as potent mimetics of the protein hormone erythropoietin
30. The Janus kinase family of protein tyrosine kinases and their role in signaling
31. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity